Picking the Right Screening Strategy

April 30, 2015
Session 4 of the Drug Design and Delivery Symposium

Blue pills labeled 4

Screening strategies are chosen based on available knowledge and tools to identify molecules that can optimized to medicines. Join Dr. David Swinney as he shares the pros and cons of different screening strategies including target-based and empirical/phenotypic-based.

*Access to this recording is an exclusive benefit for ACS Members.

What You Will Learn

  • Choice of screening strategy depends on the available knowledge and tools
  • Approaches will change for first-in-class versus advances-in-class
  • Screening strategy success is enhanced by the availability of clinically relevant biomarkers and assays that relate to biomarkers. 
  • Chemists should take more responsibility for understanding strategies, assay results and interpretation of results.

Experts

David Swinney
Institute for Rare and Neglected Diseases Drug Discovery

Barry Bunin
Collaborative Drug Discovery

Co-Produced By